Helsinn handed patent win against Teva

04-03-2016

Helsinn handed patent win against Teva

Dima Sobko / Shutterstock.com

A US court has brought to a close a patent lawsuit that cancer care company Helsinn Healthcare filed against Teva after determining that Helsinn did not trigger the on-sale bar provision when marketing its anti-cancer drug Aloxi (palonosetron). 


Helsinn Healthcare, Teva, America Invents Act, patent infringement, Aloxi, palonosetron, on-sale patent bar

LSIPR